Trial Profile
Metabolic effects and efficacy following switch to paliperidone extended-release in patients with schizophrenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2014
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 24 Jan 2014 New trial record